Literature DB >> 7846336

Transbronchial lung biopsy through the fibre optic bronchoscope. Results and complications in 452 examinations.

N Milman1, P Faurschou, E P Munch, G Grode.   

Abstract

During 1986-1989, diagnostic fibre optic bronchoscopy (FOB) was performed in local anaesthesia in 1144 consecutive patients. Of these, 405 (35%) patients, median age 59 years, had transbronchial lung biopsy (TBB) performed under fluoroscopic guidance; 47 patients had a rebronchoscopy, i.e. in total 452 FOB were evaluated. The indication for TBB was localized pulmonary lesions in 279 (69%) patients, and diffuse pulmonary lesions in 126 (31%) patients. Localized lesions: TBB yielded a clinically relevant diagnosis in 55.2% of the patients. Of the 110 patients with malignancy, the overall diagnostic strength was 45.5%. Of the 159 patients with non-malignant lesions, 65.4% were diagnosed by TBB. The diagnostic yield increased with the number of biopsy specimens (< or = 4 biopsies, 52%; > 4 biopsies, 70%. P < 0.05). In 155 patients with well defined, circumscribed lesions, the diagnostic yield of TBB increased with the size of the lesion (< 31 mm, 47%; 31-60 mm, 54%; > 60 mm, 60%, P = 0.09), and decreased with the distance of the lesion from the main carina < 61 mm, 70%; 61-100 mm, 52%; > 100 mm, 40% P < 0.02). Diffuse lesions: TBB yielded a clinically relevant diagnosis in 66.7% of the patients. Of the 15 patients with malignancy, 73.3% were diagnosed by TBB. Of the 93 patients with non-malignant lesions, 78.5% were diagnosed by TBB. The diagnostic yield showed a trend to increase with the number of biopsy specimens (< or = 4 biopsies, 65%; > 4 biopsies, 71%, P = 0.11).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 7846336     DOI: 10.1016/s0954-6111(05)80197-0

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  6 in total

Review 1.  Pneumothorax after transbronchial needle biopsy.

Authors:  Tatjana Boskovic; Milos Stojanovic; Jelena Stanic; Slobodanka Pena Karan; Gordana Vujasinovic; Dragan Dragisic; Konstantinos Zarogoulidis; Ioanna Kougioumtzi; Georgios Dryllis; Ioannis Kioumis; Georgia Pitsiou; Nikolaos Machairiotis; Nikolaos Katsikogiannis; Antonis Papaiwannou; Athanasios Madesis; Konstantinos Diplaris; Theodoros Karaiskos; Bojan Zaric; Perin Branislav; Paul Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

2.  Pneumothorax After Transbronchial Biopsy in Pulmonary Fibrosis: Lessons from the Multicenter COMET Trial.

Authors:  Jonathan A Galli; Nicholas L Panetta; Nathaniel Gaeckle; Fernando J Martinez; Bethany Moore; Thomas Moore; Anthony Courey; Kevin Flaherty; Gerard J Criner
Journal:  Lung       Date:  2017-06-16       Impact factor: 2.584

Review 3.  Iatrogenic bleeding during flexible bronchoscopy: risk factors, prophylactic measures and management.

Authors:  Maurizio Bernasconi; Coenraad F N Koegelenberg; Angela Koutsokera; Adam Ogna; Alessio Casutt; Laurent Nicod; Alban Lovis
Journal:  ERJ Open Res       Date:  2017-06-21

4.  A prospective observational study to assess PD-L1 expression in small biopsy samples for non-small-cell lung cancer.

Authors:  Akihito Tsunoda; Kei Morikawa; Takeo Inoue; Teruomi Miyazawa; Masahiro Hoshikawa; Masayuki Takagi; Masamichi Mineshita
Journal:  BMC Cancer       Date:  2019-06-07       Impact factor: 4.430

5.  Diagnostic value of the combined use of radial probe endobronchial ultrasound and transbronchial biopsy in lung cancer.

Authors:  Sang Chul Lee; Eun Young Kim; Joon Chang; Sang Hoon Lee; Chang Hoon Han
Journal:  Thorac Cancer       Date:  2020-04-16       Impact factor: 3.500

6.  Early complications in flexible bronchoscopy at a university hospital.

Authors:  Marcia Jacomelli; Stephania Silva Margotto; Sergio Eduardo Demarzo; Paulo Rogério Scordamaglio; Paulo Francisco Guerreiro Cardoso; Addy Lidvina Mejia Palomino; Viviane Rossi Figueiredo
Journal:  J Bras Pneumol       Date:  2020-06-01       Impact factor: 2.624

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.